These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12708724)

  • 1. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States).
    Egan KM; Newcomb PA; Titus-Ernstoff L; Trentham-Dietz A; Mignone LI; Farin F; Hunter DJ
    Cancer Causes Control; 2003 Feb; 14(1):43-51. PubMed ID: 12708724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.
    Hunter DJ; Hankinson SE; Hough H; Gertig DM; Garcia-Closas M; Spiegelman D; Manson JE; Colditz GA; Willett WC; Speizer FE; Kelsey K
    Carcinogenesis; 1997 Nov; 18(11):2127-32. PubMed ID: 9395212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype.
    Morabia A; Bernstein MS; Bouchardy I; Kurtz J; Morris MA
    Am J Epidemiol; 2000 Aug; 152(3):226-32. PubMed ID: 10933269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
    Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.
    Ambrosone CB; Kropp S; Yang J; Yao S; Shields PG; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):15-26. PubMed ID: 18187392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
    van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Kromhout D; Bueno de Mesquita HB
    Pharmacogenetics; 2003 Jul; 13(7):399-407. PubMed ID: 12835615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.
    Baumgartner KB; Schlierf TJ; Yang D; Doll MA; Hein DW
    Toxicol Sci; 2009 Nov; 112(1):211-20. PubMed ID: 19692670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
    Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
    Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.
    Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.
    Ambrosone CB; Freudenheim JL; Graham S; Marshall JR; Vena JE; Brasure JR; Michalek AM; Laughlin R; Nemoto T; Gillenwater KA; Shields PG
    JAMA; 1996 Nov; 276(18):1494-501. PubMed ID: 8903261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.